BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

FEMCON Pages on BioPortfolio:

Biotechnology News FEMCON Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/FEMCON-news.htm...

BioPortfolio - Femcon
Femcon - BioPortfolio - Indepth. ... Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation ...
http://www.bioportfolio.com/indepth/Femcon.html...

Biotechnology News LOESTRIN Search
13 Sep 2009 ... Warner Chilcott Files New Lawsuit for Infringement of Loestrin 24 FE and Femcon FE Patents ARDEE, Ireland, Sept. ...
http://www.bioportfolio.co.uk/LOESTRIN-news.htm...

BioPortfolio - Femcon - InDepth
(http://www.bioportfolio.com/indepth/Femcon.html) - Regularly Updated. ***. Resources from the NCBI used in this document, NCBI's standard disclaimer ...
http://www.bioportfolio.com/indepth/Femcon.pdf...

BioPortfolio's Approved Drugs News by Tradename - F
FEMCON · FEMHRT · FEMINONE · FEMOGEN · FEMPATCH · FEMRING · FEMSTAT · FEMTRACE · FENOFIBRATE · FENOGLIDE · FENOLDOPAM_MESYLATE · FENOPROFEN_CALCIUM ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_p...

BioPortfolio - Watson Pharmaceuticals, Inc. - Warner Chilcott and ...
Loestrin(R) 24 and Femcon(R) Fe Settlement and License Agreements ... The agreement covering Femcon(R) Fe will permit Watson to ...
http://www.bioportfolio.com/news/Warner_Chilcott_and_Watson_...

BioPortfolio - Lupin Pharmaceuticals, Inc - Profile
Warner Chilcott Files New Lawsuit for Infringement of Loestrin 24 FE and Femcon FE Patents. Pharma Live: Sep 12 2009 7:58AM Matching: lupin pharmaceuticals ...
http://www.bioportfolio.com/biocorporate/25878-Lupin%252BPha...

BioPortfolio - Warner Chilcott
Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents, SmartBrief: Sep 13 2009 1:14AM Matching: warner chilcott
...
http://www.bioportfolio.com/biocorporate/10947-Warner_Chilco...

BioPortfolio - Loestrin
Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation, 12th January, 2009 ...
http://www.bioportfolio.com/indepth/Loestrin.html...

BioPortfolio Limited Women's Reproductive Disorders Therapeutics ...
2.15.3 Warner Chilcott Sues Watson Over Generic Femcon FE Application 2.15.4 Barr Attempts to Prevent Watson Marketing Seasonique ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1152.html...

Results from other life science and pharmaceutical sites:

FEMCON Fe
Information for Vermont Prescribers of Prescription Drugs. FEMCON Fe о. ( norethindrone and ethinyl estradiol tablets) 0.4mg/35mcg ...
http://www.wcrx.com/pdfs/vt/femcon_long.pdf...

Warner Chilcott Files Lawsuit Against Barr Laboratories for ...
24 Sep 2007 ... 6667050 (the "050 Patent") which covers FEMCON FE, the first and only oral contraceptive that offers women the option of chewing their daily ...
http://www.biospace.com/news_story.aspx?NewsEntityId=70794...

Warner Chilcott
Doryx · Loestrin 24 Fe · femhrt · Femcon Fe · Ovcon 50 · Sarafem · PRODUCTS · RESEARCH · CAREERS · INVESTOR RELATIONS · SELECT ONE OF OUR PRODUCTS ...
http://www.wcrx.com/...

[Urogynecologic follow-up after conservative therapy of stress ...
Vaginal cones (Femcon) are widely used for training the pelvic floor muscles. We investigated 60 women (mean age 50.7 years). After an exercise course with ...
http://www.ncbi.nlm.nih.gov/pubmed/7926569...

Warner Chilcott
FEMCON® Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous ... FEMCON Fe is indicated for the prevention of pregnancy in women who choose
...
http://www.wcrx.com/products_women_healthcare.jsp...

Summary of WARNER CHILCOTT LTD - Yahoo! Finance
27 Feb 2009 ... FEMCON FE generated revenues of $45.8 million in the year ended ... The increase in FEMCON FE net sales in the year ended December 31, ...
http://biz.yahoo.com/e/090227/wcrx10-k.html...

[Urogynecologic examination in women after conservative treatment ...
[Urogynecologic examination in women after conservative treatment of urinary stress incontinence using the vaginal cone (Femcon)]. [Article in Czech] ...
http://www.ncbi.nlm.nih.gov/pubmed/8925165...

Summary of WARNER CHILCOTT LTD - Yahoo! Finance
In January 2009, we entered into settlement and license agreements with Watson Pharmaceuticals, Inc. to resolve pending patent litigation relating to FEMCON
...
http://biz.yahoo.com/e/090511/wcrx10-q.html...

Warner Chilcott Reports Operating Results for the Quarter Ended ...
FEMCON FE generated revenue of $11.4 million in the quarter ended September 30 ... The increase in FEMCON FE net sales was primarily due to a 42.5% increase
...
http://www.prnewswire.com/news-releases/warner-chilcott-repo...

Warner Chilcott
Femcon®Fe (chewable oral contraceptive) • Femtrace® (oral hormone therapy) • Doryx® delayed-release tablets (oral adjunctive therapy for acne) ...
http://www.wcrx.com/research.jsp...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.